PATENT CLAIM ANALYSIS

Application Number: 15944568
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["424", "450000"]

Abstract:
A liposome formulation for delivery of Wnt signal pathway inhibitor is provided herein, which comprises lipid molecules and Wnt signal pathway inhibitor, wherein Wnt signal pathway inhibitor encapsulated within the liposome formulation has a concentration ranging from 0.07 mg/ml to 0.5 mg/ml.

Claim (Index 10):
The liposome formulation of  claim 1 , wherein the liposome formulation is an oral formulation, or a subcutaneous injection formulation, or an intravenous injection formulation.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15550472', '11371586', '15127081', '13815311', '15253307']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7232786942384101
- 35 USC 102 Novelty (BERT): 0.4628294782580716
- Combined Prediction Score: 0.6972337726403763
- Mean Citation Score: 153.12702399999995
- Max Citation Score: 157.0784
- Similarity Product: 124.62337003593444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test